Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 21;27(1):303.
doi: 10.1186/s40001-022-00938-y.

Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study

Maryam Erfaninejad  1 , Arash Salahshouri  2 , Nasrin Amirrajab  3
Affiliations

Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study

Maryam Erfaninejad et al. Eur J Med Res. .

Abstract

Background: Non-adherence of patients with vulvovaginal candidiasis (VVC) to treatment recommendations leads to treatment failure and recurrence of infection. Therefore, this qualitative study was conducted to identify barriers and facilitators of observance of treatment among women afflicted with vulvovaginal candidiasis.

Methods: This qualitative study was conducted through 26 in-depth unstructured interviews with 24 patients and 2 gynecologists using purposeful sampling with maximum variation in Ahvaz, southwest Iran. Interviews were conducted in person at health centers and the gynecologist's offices. MAXQDA 10 software and conventional content analysis were used for data analysis.

Results: The findings showed barriers and facilitator factors of adherence to treatment in women with VVC. Some of these factors lead to an increase in adherence to treatment, and others play the role of hindering factors. These factors were classified into two main categories: patients' beliefs and patients' fears and concerns.

Conclusion: The results of this study showed that many of the behaviors of patients from the acceptance of the diagnosis process to treatment are rooted in the patient's beliefs and fears. Therefore, it seems necessary to design and carry out interventions based on the findings of this study, which can be used in the development of appropriate solutions, treatment guidelines, and adopting a policy for treatment adherence.

Keywords: Qualitative research; Recurrent vulvovaginal candidiasis; Treatment failure.

PubMed Disclaimer

Conflict of interest statement

The authors report there are no competing interests to declare.

Figures

Fig. 1
Fig. 1
Summary of data analysis
See this image and copyright information in PMC

References

    1. Pereira LC, Correia AF, da Silva ZDL, de Resende CN, Brandão F, Almeida RM, et al. Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence. Eur J Clin Microbiol Infect Dis. 2021;40(8):1681–1693. doi: 10.1007/s10096-021-04199-1. - DOI - PMC - PubMed
    1. Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women’s Health. 2019;19(1):48. doi: 10.1186/s12905-019-0748-8. - DOI - PMC - PubMed
    1. Shi Y, Zhu Y, Fan S, Liu X, Liang Y, Shan Y. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis. BMC Infect Dis. 2020;20(1):287. doi: 10.1186/s12879-020-04985-w. - DOI - PMC - PubMed
    1. Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 2020;8(2):144. doi: 10.3390/microorganisms8020144. - DOI - PMC - PubMed
    1. Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15–21. doi: 10.1016/j.ajog.2015.06.067. - DOI - PubMed

LinkOut - more resources